Alzheimer’s Drug Poses a Dilemma for the F.D.A.
Henry Magendantz, 84, was unhooked from an I.V. after receiving an infusion of the experimental Alzheimer’s drug, aducanumab.Credit…Kayana Szymczak for The New York Times Alzheimer’s Drug Poses a Dilemma for the F.D.A. If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some… Read More »